–Researcher at GC Green Cross is conducting research. Source = GC Green Cross – [이코노믹리뷰=황진중 기자] GC Green Cross (006280) starts shipping’Hunterase ICV (intracerebroventricular)’. GC Green Cross (CEO Heo Eun-cheol) announced on the 3rd that it will ship Hunterase ICV, the world’s first severe hunter syndrome treatment, to Japan. According to an analysis that the … Read more
–▲ Chinese students are standing around after making large AIDS ribbons with red scarves for World AIDS Day. Source = Newsis – [이코노믹리뷰=황진중 기자] In the second quarter of this year, the number of people infected with AIDS and human immunodeficiency virus (HIV) in China increased by 100,000 in one year to 820,000. China’s state-run … Read more
–A novel coronavirus seen with an electron microscope. The protrusions surrounding the virus particles can be observed with an enlarged electron microscope. It was named Coronavirus, where virus particles showed crown-shaped projections. ‘Corona’ means crown in Latin. Source = Macrogen – [이코노믹리뷰=황진중 기자] Corona 19) More than half of patients showed heart damage left after … Read more
–Jin Yang-gon, CEO of HLB. Source = Newsis – [이코노믹리뷰=황진중 기자] HLB (028300) is scheduled to disclose its position on the 16th in relation to the report on the suspicion of false disclosure of FDA clinical results. On the website, HLB said, “After receiving a request from the financial authorities, we express our deep regret … Read more
–Daewoong Pharmaceutical succeeded in winning the 1st trillion club. Photo = Economic Review Reporter Hwang Jin-joong – [이코노믹리뷰=황진중 기자] Daewoong Pharmaceutical (069620) announced on the 15th that it recorded 17 billion won in operating profit on a consolidated basis last year. This is a 62% decrease from the previous year. Last year’s sales amounted to … Read more
–AstraZeneca Academy House view. Source = Newsis – [이코노믹리뷰=황진중 기자] The German Vaccination Committee recommended that AstraZeneca’s COVID-19 vaccine be administered only to those aged 18-64. It is considered that clinical data is insufficient on whether the vaccine is effective for people over 65 years of age. According to the BBC on the 28th (local … Read more
–CT-P59 (ingredient name regdanvimab), a novel corona 19 antibody drug developed by Celltrion. Source = Newsis – [이코노믹리뷰=황진중 기자] It is expected that Celltrion (068270) will be transferred to the Ministry of Food and Drug Safety for approval of the new Corona 19 antibody drug CT-P59 (ingredient name Regdanvimab), which is being developed by itself. … Read more
–Celltrion is producing commercially available quantities of’CT-P59′, a new corona19 antibody drug. Source = Celltrion – [이코노믹리뷰=황진중 기자] The Ministry of Food and Drug Safety emphasized that a domestic antibody treatment development company plans to apply for approval in December. The Ministry of Food and Drug Safety is undergoing a preliminary review on three vaccine … Read more